Recommendations for managing Aspergillus osteomyelitis and joint infections based on a review of the literature
- 30 June 2006
- journal article
- review article
- Published by Elsevier in Journal of Infection
- Vol. 52 (6) , 405-414
- https://doi.org/10.1016/j.jinf.2005.08.016
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Antimykoticum 5-Fluorocytosin (Oral Antimycotic Agent, 5-Fluorocytosine)Mycoses, 2009
- VoriconazolePublished by Elsevier ,2003
- In Vitro Synergy of Caspofungin and Itraconazole against Aspergillus spp.: MIC versus Minimal Effective Concentration End PointsAntimicrobial Agents and Chemotherapy, 2003
- Aspergillus Discitis With Acute Disc AbscessSpine, 1994
- Carpal Aspergillus osteomyelitis: Case report and review of the literatureThe Journal of Hand Surgery, 1993
- Liposomal and Lipid Formulations of Amphotericin BClinical Pharmacokinetics, 1992
- In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agentsDiagnostic Microbiology and Infectious Disease, 1992
- Aspergillus DiscitisPublished by Wolters Kluwer Health ,1988
- Susceptibility of Aspergillus to 5-fluorocytosine and amphotericin B alone and in combinationJournal of Antimicrobial Chemotherapy, 1978
- Clinical Pharmacokinetics of RifampicinClinical Pharmacokinetics, 1978